Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

KX-826 is a potential hair loss treatment, with users discussing its effectiveness compared to finasteride and concerns about its trial results. Some users express skepticism about new treatments, while others discuss the potential of androgen receptor degraders and the need to manage drug resistance.

Oral minoxidil is considered unsafe due to severe side effects and requires close medical supervision, while oral finasteride is viewed as safe and effective. There is debate over the fear-mongering around finasteride and the downplaying of minoxidil's risks, with some users advocating for proper health screenings before use.

The conversation is about the availability of WINLEVI, a hair loss treatment, and the possibility of getting it compounded. The user is seeking information on when they can obtain the treatment.

Oral minoxidil is considered a safe and effective treatment for hair loss at low dosages, with minimal cardiac risks. Users report positive results, though some experience side effects like increased heart rate and skin changes, and consulting a doctor is advised.

The user has been taking Finasteride for over a year without noticing any effects on hair loss, and others suggest that it may not work for everyone. Some recommend trying Dutasteride as an alternative treatment.

Nanoxidil, a minoxidil derivative, is being discussed as a potential hair loss treatment. Users are curious about its effectiveness and side effects compared to minoxidil, with some noting it includes additional ingredients like caffeine.

Creatine may be linked to hair loss, possibly due to contamination with steroids. Users suggest avoiding creatine if it causes hair loss, as mislabeled products could be the issue.

Stem cell-related treatments and drugs like RCGD423 and WAY are being tested for hair growth. Clinics are conducting tests on patients who haven't had previous treatments.

Low-Level Laser Therapy (LLLT) is seen as a safe and effective method for maintaining hair and promoting regrowth in androgenetic alopecia (AGA) and male pattern baldness (MPB), with devices like the HairMax LaserComb® and iRestore helmet being popular. Some users and professionals are skeptical about its long-term effectiveness and cost.

A new topical treatment called RT1640 claims to reverse AGA using cyclosporine A, Minoxidil, and a new chemical entity, RT175. Users are skeptical due to lack of clinical trial data and inconsistent before-and-after photos.

The conversation discusses concerns about creatine potentially increasing DHT levels, which might counteract the effects of finasteride and lead to hair loss. Users suggest caution with creatine use, as evidence is inconclusive, and recommend monitoring hair health while using it.

Zinc and iron supplements alone are unlikely to cure baldness, but they might help if there's a deficiency. Effective treatments for hair loss include finasteride and minoxidil.

Stem cell hair restoration lacks scientific evidence and is often considered a scam. Effective hair loss treatments include hair transplants, Minoxidil, and Finasteride, but stem cell treatments are not proven.

The conversation is about making a topical finasteride solution for hair loss, discussing methods to dissolve finasteride tablets in minoxidil while avoiding fillers. Users debate the practicality of using pure finasteride powder versus tablets due to filler content.

The conversation discusses obtaining dutasteride in the UK for hair loss, with users recommending Oxford Online Pharmacy and Voy as sources. Some users mention combining dutasteride with minoxidil, while others discuss the effectiveness of topical versus oral options.

PP405 is in a phase 3 trial for hair loss treatment, with the study expected to run until June 2028. Minoxidil and finasteride remain key treatments, with hopes for PP405 to offer a new mechanism of action.

Pelage Pharmaceuticals is starting Phase 3 trials for PP405 in September 2026, with potential market release by 2030. Users discuss various hair loss treatments like minoxidil, finasteride, RU58841, kx, breezula, and gt20029, expressing hope for future hair restoration.

Switching from powdered dutasteride to softgel significantly reduced DHT levels, suggesting softgels are more effective due to better bioavailability. Users discuss the ineffectiveness of compounded forms and emphasize the importance of proper formulation for absorption.

The user experienced significant hair improvement using oral finasteride and minoxidil but is now facing a secondary hair shedding phase after nine months, possibly linked to weight loss or seasonal changes. Despite concerns, others in the conversation suggest that such shedding is normal and temporary.

An arthritis drug restored significant hair in people with alopecia areata, but it is not effective for male pattern baldness. The drug, Upadacitinib, has serious side effects and is expensive.

Switching from finasteride to dutasteride led to retrograde alopecia for some users, with mixed results on hair regrowth. Some experienced increased shedding, while others saw regrowth or no change.

Exosome therapy for hair loss is questioned, with microneedling and topical minoxidil/dutasteride being more supported treatments. Concerns are raised about testosterone therapy affecting hair loss, and the lack of standardization and approval for exosome products.

A user shared their experience with hair loss treatments, initially using oral dutasteride (Avodart) and minoxidil, and recently switching to a topical dutasteride solution. They reported significant hair improvement over time and are hopeful about the new topical treatment.

The user is considering a hair transplant due to thinning hair but has been using dutasteride and topical minoxidil for 4 years, which has stabilized and thickened their hair. They are advised to continue with current treatments and consider other options like microneedling, as transplants may not be ideal for diffuse thinning.

A new hair growth drug claims to reverse severe hair loss without using minoxidil, finasteride, or hormone-altering drugs, but many are skeptical due to lack of evidence and concerns about misleading claims. The drug is expected to be released in early 2027, but its legitimacy is questioned.

The conversation discusses purchasing hair loss treatments like minoxidil and finasteride from Indiamart, with users advising to stick to reputable Indian pharmaceutical brands. Concerns about product authenticity and safety, especially regarding minoxidil's potential side effects, are also highlighted.

Minoxidil formulations often use propylene glycol (PG) for stability and effectiveness, but PG-free alternatives like foams and PEG-based solutions can also be effective with less irritation. Concerns exist about the quality of PG-free minoxidil from lesser-known brands, especially from India, due to potential manufacturing issues.

The user is considering switching from topical finasteride to RU58841 or KX826 to reduce side effects but decides to stick with finasteride for now. Users discuss the effectiveness and risks of RU58841 and KX826, with finasteride being considered the most reliable option.

Oral minoxidil users report mixed results, with some experiencing hair regrowth and others noting reduced effectiveness over time. Many combine it with finasteride or dutasteride, and some face challenges obtaining prescriptions, especially in certain countries.

A 20-year-old male has seen significant hair regrowth after using dutasteride, oral minoxidil, dermastamping, and ketoconazole shampoo. Users confirm progress and suggest adding RU58841 and maintaining consistency for continued results.